Antithrombin III: Substitutive Treatment of the Hereditary Deficiency

Thromb Haemost 1980; 43(01): 072
DOI: 10.1055/s-0038-1650020

Letter to the Editor

Schattauer GmbH Stuttgart

P Laharrague M. D.

Laboratory of hematology and Cardiovascular department, CHU Toulouse Rangueil, 31054 Toulouse France

Department of infectious disease, CHU Toulouse Purpan, 31052 Toulouse France

,

R Biermé M. D.

Laboratory of hematology and Cardiovascular department, CHU Toulouse Rangueil, 31054 Toulouse France

Department of infectious disease, CHU Toulouse Purpan, 31052 Toulouse France

,

A Cérène M. D.

Laboratory of hematology and Cardiovascular department, CHU Toulouse Rangueil, 31054 Toulouse France

Department of infectious disease, CHU Toulouse Purpan, 31052 Toulouse France

,

A Boucays M. D.

Laboratory of hematology and Cardiovascular department, CHU Toulouse Rangueil, 31054 Toulouse France

Department of infectious disease, CHU Toulouse Purpan, 31052 Toulouse France

,

P Massip M. D.

Laboratory of hematology and Cardiovascular department, CHU Toulouse Rangueil, 31054 Toulouse France

Department of infectious disease, CHU Toulouse Purpan, 31052 Toulouse France

References
1 Gruenberg J, Smallridge R, Rosenberg R. Inherited antithrombin III deficiency causing mesenteric venous infarction. A new clinical entity. Ann Surg 1975; 181: 791-794
2 Thaler E, Niessner H, Kleinberger G, Gassner A. Antithrombin III replacement therapy in patients with congenital and acquired antithrombin III deficiency. Proc VIIth Int Congr Thrombos Haemostas London 1979
3 Marciniak E, Farley C, De Simone P. Familial thrombosis due to antithrombin III deficiency. Blood 1974; 43: 219-231
4 Tullis J, Watanabe K. Platelet antithrombin deficiency. A new clinical entity. Amer J Med 1978; 65: 472-478